Phase 2 Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 80 years old
- People who have been confirmed through laboratory testing to have cervical cancer of a specific type called squamous cell carcinoma
- People whose cervical cancer has been staged (using the 2018 FIGO system) as Stage Ib3, II, IIIB, or IIIC1
- People whose treatment plan includes a full course of pelvic radiation therapy combined with platinum-based chemotherapy (cisplatin or carboplatin) given at the same time, for at least 5 rounds
- People with a general health and activity level rated between 0 and 2 on a standard medical scale (meaning able to carry out at least some daily activities) (confirm with trial site)
- People with a life expectancy of more than 6 months
- People who are able to lie still for more than 30 minutes
- People who are willing to participate and able to sign the consent form on their own
- People whose recent blood test results (taken within 14 days before joining) meet specific levels for blood cell counts, kidney function, and liver function (confirm with trial site for exact values)
- People who have completed all required baseline health checks before the trial begins
- People who are able to attend regular follow-up appointments
Who may not be able to join:
- People who have previously received radiotherapy or chemotherapy
- People who have already had surgery to remove the cervical cancer
- People with a past history of any other cancer
- People who are pregnant or breastfeeding
- People with serious uncontrolled conditions affecting the heart, kidneys, digestive system, lungs, blood, or nervous system
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 15801390180
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Acute non-hematological toxicity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.